| Page 898 | Kisaco Research
 

Takanori Abe

Managing Partner
ABE & PARTNERS

Mr. ABE is an Attorney-at-Law, admitted in both Japan and New York. He is currently a Guest Professor of Osaka University Graduate School of Medicine and formerly a lecturer of The University of Tokyo Graduate School of Medicine and Faculty of Medicine.  He is an arbitrator in Japan and sit on various positions in Japanese medical/pharmaceutical societies.

Takanori Abe

Managing Partner
ABE & PARTNERS

Takanori Abe

Managing Partner
ABE & PARTNERS

Mr. ABE is an Attorney-at-Law, admitted in both Japan and New York. He is currently a Guest Professor of Osaka University Graduate School of Medicine and formerly a lecturer of The University of Tokyo Graduate School of Medicine and Faculty of Medicine.  He is an arbitrator in Japan and sit on various positions in Japanese medical/pharmaceutical societies.

Mr. ABE works in wide areas of international and corporate matters with a focus on intellectual property law and international commerce. The patent litigations that he has participated covers the fields of pharmaceuticals, chemistry, electronics and machinery, which involve advanced technology such as biotechnology, semiconductors, etc., and which are cross-border matters. He has extensive experience on representing and advising multinational and domestic clients in pharmaceutical industry and is currently involved in the drastic battle between brands and also the one between brands and generics. He also has experience in trademark, copyright and unfair competition litigation.

For Mr. ABE’s detail information and activities, please visit www.abe-law.com or email to: [email protected]

Sample Attendee LIst
2022 Sample Attendee List
 
Trade Secret IP Protection & Management EU Summit
14-15 Nov 2023
Brussels, Belgium
HIGHLIGHTS INCLUDE:Reviewing recent European trade secret cases to discover the latest legal nuances and how they impact industry in-house executivesDevising a successful in-house trade secret management and risk mitigation strategyOptimising your internal cyber framework by understanding the importance of privacy, data and cyber security for trade secret IP protectionIdentifying your company’s commercial value and exploring how to audit your company’s trade secret IPEstablishing the importance of trade secret IP in anticipation of the Rise of AIThis is a must-attend event for anyone working within industry IP, legal, cyber security, HR and compliance functions.
Attendee List 2021
 
Privacy-Enhancing Technology Summit Asia-Pacific
16 Jul 2024
Marina Bay Sands Singapore, 10 Bayfront Ave, Singapore 018956
Supported by the IMDA, the Privacy-Enhancing Technology Summit Asia-Pacific returns to Singapore from July 16.By attending the only series specifically focused on PETs, you will have the opportunity to connect with adopters, solution providers, academics, and government and regulatory bodies to explore use cases, and proof of concepts, and overcome barriers to PET adoption. 
 

Dr Yuri Martina

Chief Medical Officer
Destiny Pharma

Dr Yuri Martina

Chief Medical Officer
Destiny Pharma

Dr Yuri Martina

Chief Medical Officer
Destiny Pharma
 

Ted Suh

VP, Chemistry
Orionis Biosciences

Ted is a medicinal chemist with extensive experience in pharmaceutical drug discovery and development. He has held various leadership positions in pharma, including at Glaxo and Eisai, contributing to the discovery of several clinical candidates in the areas of metabolic disease, oncology and autoimmune diseases. His expertise ranges from combinatorial chemistry to drug discovery using complex molecules like natural products.

Ted Suh

VP, Chemistry
Orionis Biosciences

Ted Suh

VP, Chemistry
Orionis Biosciences

Ted is a medicinal chemist with extensive experience in pharmaceutical drug discovery and development. He has held various leadership positions in pharma, including at Glaxo and Eisai, contributing to the discovery of several clinical candidates in the areas of metabolic disease, oncology and autoimmune diseases. His expertise ranges from combinatorial chemistry to drug discovery using complex molecules like natural products. At Orionis, his attention has turned to the discovery and optimization of molecular glues, with a special focus on the evolution of chemistries for a diverse range of monovalent types of glues. Ted received a B.A. degree in chemistry from Yale University and a Ph.D. degree in chemistry from Harvard University.

 

Scott Parkinson

Founder
AQABELA

Scott Parkinson

Founder
AQABELA

Scott Parkinson

Founder
AQABELA
 

Leah Ramoutar

Head of TCFD Implementation
Phoenix Group

Leah is the Head of TCFD at Phoenix Group where she oversees all the Group’s activities related to climate risk and leads on a number of ESG, climate and nature-related projects.  Prior to joining Phoenix in 2009, Leah spent two years in Investment Management and five years in the audit and corporate finance advisory practice at KPMG. Leah started her career in sustainable finance, working with SME clients across the Caribbean and South America. She holds a B.Sc. in Business Management from King’s College, London and is a Fellow Chartered Accountant.

Leah Ramoutar

Head of TCFD Implementation
Phoenix Group

Leah Ramoutar

Head of TCFD Implementation
Phoenix Group

Leah is the Head of TCFD at Phoenix Group where she oversees all the Group’s activities related to climate risk and leads on a number of ESG, climate and nature-related projects.  Prior to joining Phoenix in 2009, Leah spent two years in Investment Management and five years in the audit and corporate finance advisory practice at KPMG. Leah started her career in sustainable finance, working with SME clients across the Caribbean and South America. She holds a B.Sc. in Business Management from King’s College, London and is a Fellow Chartered Accountant.